Classification Nuance. The OpenFDA dataset, which draws from the Structured Product Labeling (SPL) files, often includes multiple classification fields, and the specific string "Phosphate Binder [EPC]" may only be assigned to a single product. The other drugs are likely classified using: More Specific Classes: Many of those drugs (like sevelamer, ferric citrate, etc.) may be classified by their specific mechanism or chemical group, which also acts as a phosphate binder. Example: A drug might be classified as "Iron-Containing Compound [EPC]" or "Aluminum-Containing Compound [EPC]" instead of the more general "Phosphate Binder [EPC]". Different Classification Fields: The NDC data contains several classification fields. You might be checking the Established Pharmacological Class (pharm_class_epc), but the other drugs might be listed under: Mechanism of Action (pharm_class_moa), Physiological Effect (pharm_class_pe)
  Home  

Enter a class name or drug name above to search the database.

CD38-directed Cytolytic Antibody [EPC]

NDC Number Brand Name Generic Name Manufacturer Dosage Form DEA Sch. Marketing Start Date
0024-0654 Sarclisa isatuximab Sanofi-Aventis U.S. LLC INJECTION, SOLUTION, CONCENTRATE 2020-03-02
0024-0656 Sarclisa isatuximab Sanofi-Aventis U.S. LLC INJECTION, SOLUTION, CONCENTRATE 2020-03-02
57894-502 DARZALEX Daratumumab Janssen Biotech, Inc. INJECTION, SOLUTION, CONCENTRATE 2015-11-16
57894-503 Darzalex Faspro daratumumab and hyaluronidase-fihj (human recombinant) Janssen Biotech, Inc. INJECTION 2020-05-01
57894-505 Darzalex IV Daratumumab Janssen Biotech, Inc. INJECTION, SOLUTION, CONCENTRATE 2021-10-15



 [EPC] Established Pharmacological Classification 

Loading full table content...